The role and reversibility of vascular alterations in the development, progression and regression of metabolic dysfunction-associated steatotic liver disease (MASLD)
Source
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2026,259 p.
MASLD, MASH, and the CKM spectrum : a roadmap for multiorgan clinical trial design
Source
Journal of the American College of Cardiology - ISSN 0735-1097-87:15 (2026) p. 2006-2033
Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis
Source
Nature genetics - ISSN 1061-4036- (2026) p.
Metabolic dysfunction-associated steatotic liver disease is associated with vascular dysfunction in type 1 diabetes
Source
Cardiovascular diabetology - ISSN 1475-2840-25:1 (2026) p. 1-16
Is FIB-4 the right tool for screening for liver fibrosis?
Source
Annals of Hepatology - ISSN 1665-2681-31:2 (2026) p. 1-8